821 related articles for article (PubMed ID: 16406762)
21. Soy protein with or without isoflavones failed to preserve bone density in gonadal hormone-deficient male rat model of osteoporosis.
Juma SS; Ezzat-Zadeh Z; Khalil DA; Hooshmand S; Akhter M; Arjmandi BH
Nutr Res; 2012 Sep; 32(9):694-700. PubMed ID: 23084642
[TBL] [Abstract][Full Text] [Related]
22. Isoflavones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isoflavones alone.
Breitman PL; Fonseca D; Cheung AM; Ward WE
Bone; 2003 Oct; 33(4):597-605. PubMed ID: 14555264
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a soybean product fujiflavone P40 as an antiosteoporotic agent in rats.
Hidaka S; Okamoto Y; Miyazaki K; Uesugi T
Phytother Res; 2003 Feb; 17(2):112-9. PubMed ID: 12601671
[TBL] [Abstract][Full Text] [Related]
24. Combined effect of soy isoflavones and vitamin D3 on bone loss in ovariectomized rats.
Chang KL; Hu YC; Hsieh BS; Cheng HL; Hsu HW; Huang LW; Su SJ
Nutrition; 2013 Jan; 29(1):250-7. PubMed ID: 22858193
[TBL] [Abstract][Full Text] [Related]
25. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
Wang ML; Massie J; Perry A; Garfin SR; Kim CW
Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
[TBL] [Abstract][Full Text] [Related]
26. [Soy isoflavones with supplemental calcium provide protection against the loss of bone mass and influence insulin-like growth factor (IGF)-I after ovariectomy in rat].
Cheng MW; Liu JF; Yi GQ; Zhang XP; Zhu QH; Liu LG
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Sep; 40(5):328-31. PubMed ID: 17166423
[TBL] [Abstract][Full Text] [Related]
27. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women.
Alekel DL; Germain AS; Peterson CT; Hanson KB; Stewart JW; Toda T
Am J Clin Nutr; 2000 Sep; 72(3):844-52. PubMed ID: 10966908
[TBL] [Abstract][Full Text] [Related]
28. Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis.
Devareddy L; Hooshmand S; Collins JK; Lucas EA; Chai SC; Arjmandi BH
J Nutr Biochem; 2008 Oct; 19(10):694-9. PubMed ID: 18328688
[TBL] [Abstract][Full Text] [Related]
29. Protective actions of soy isoflavones and n-3 PUFAs on bone mass in ovariectomized rats.
Watkins BA; Reinwald S; Li Y; Seifert MF
J Nutr Biochem; 2005 Aug; 16(8):479-88. PubMed ID: 16043030
[TBL] [Abstract][Full Text] [Related]
30. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.
Mathey J; Mardon J; Fokialakis N; Puel C; Kati-Coulibaly S; Mitakou S; Bennetau-Pelissero C; Lamothe V; Davicco MJ; Lebecque P; Horcajada MN; Coxam V
Osteoporos Int; 2007 May; 18(5):671-9. PubMed ID: 17333448
[TBL] [Abstract][Full Text] [Related]
31. Effects of dietary equol administration on ovariectomy induced bone loss in Sprague-Dawley rats.
Rachoń D; Seidlová-Wuttke D; Vortherms T; Wuttke W
Maturitas; 2007 Nov; 58(3):308-15. PubMed ID: 17961939
[TBL] [Abstract][Full Text] [Related]
32. Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats.
Luo Y; Zhang L; Wang WY; Hu QF; Song HP; Su YL; Zhang YZ
Bone; 2013 Aug; 55(2):439-48. PubMed ID: 23500174
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats.
Ren P; Ji H; Shao Q; Chen X; Han J; Sun Y
Pharmacology; 2007; 79(3):129-36. PubMed ID: 17179740
[TBL] [Abstract][Full Text] [Related]
34. Dietary soy protein maintains some indices of bone mineral density and bone formation in aged ovariectomized rats.
Blum SC; Heaton SN; Bowman BM; Hegsted M; Miller SC
J Nutr; 2003 May; 133(5):1244-9. PubMed ID: 12730404
[TBL] [Abstract][Full Text] [Related]
35. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
[TBL] [Abstract][Full Text] [Related]
36. Effects of treatment with parathyroid hormone 1-84 on quantity and biomechanical properties of thoracic vertebral trabecular bone in ovariectomized rhesus monkeys.
Fox J; Newman MK; Turner CH; Guldberg RE; Varela A; Smith SY
Calcif Tissue Int; 2008 Mar; 82(3):212-20. PubMed ID: 18297227
[TBL] [Abstract][Full Text] [Related]
37. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice.
Fonseca D; Ward WE
Bone; 2004 Aug; 35(2):489-97. PubMed ID: 15268901
[TBL] [Abstract][Full Text] [Related]
38. Suppressive effects of genistein dosage and resistance exercise on bone loss in ovariectomized rats.
Nakajima D; Kim CS; Oh TW; Yang CY; Naka T; Igawa S; Ohta F
J Physiol Anthropol Appl Human Sci; 2001 Sep; 20(5):285-91. PubMed ID: 11759267
[TBL] [Abstract][Full Text] [Related]
39. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
40. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
